CONFIDENTIALSeparation Agreement and Release • March 8th, 2019 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Technology Transfer and License Agreement between Genentech, Inc. and Proteostasis Therapeutics, Inc.Technology Transfer and License Agreement • March 8th, 2019 • Proteostasis Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Technology Transfer and License Agreement (“Agreement”) is made and entered into, effective as of December 13, 2018 (“Effective Date”), by and between Genentech, Inc., a Delaware corporation, having a principal place of business at 1 DNA Way, South San Francisco, California 94080 (“Genentech”) and Proteostasis Therapeutics, Inc. , a Delaware corporation, having a principal place of business at 80 Guest Street, Suite 500, Boston, MA 02135 (“PTI”). Genentech and PTI are each referred to herein individually as a “Party” and collectively as the “Parties.”
October 19, 2018 Proteostasis Therapeutics, Inc.Proteostasis Therapeutics, Inc. • March 8th, 2019 • Pharmaceutical preparations
